AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12616578
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) with exposure-based treatment
Trial: 7048518
Drug: Hormonal treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal treatment alone with delayed chemotherapy until tumor progression
Trial: 30220262
Drug: Carp pituitary
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carp pituitary extract (CPE; 2.0 mg/kg)
Trial: 12122623
Drug: Lidocaine HCl
RxNorm normalized name: lidocaine HCl
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine HCl aerosol (4 mg/kg of 10% lidocaine HCl applied eight times daily)
Trial: 30220262
Drug: NaCl solution
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaCl solution 0.9% (control group; 0.5 ml/kg)
Trial: 7732992
Drug: Thrombolysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolysis with intravenous tissue plasminogen activator or urokinase
Trial: 31992372
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (20 g/d)
Trial: 18257603
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of donepezil (15 mg/day for weeks 1-12; 20 mg/day for weeks 13-24)
Trial: 30558079
Drug: Loxonin tablet
DrugBank: Loxoprofen (DB09212)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Loxonin tablet (60 mg of loxoprofen)
Trial: 29850244
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg/day
Trial: 17274520
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose sublingual specific immunotherapy with a 6-grass-pollen mixture
Trial: 28498942
Drug: 4000 IU
RxNorm normalized name: Cholecalciferol 4000 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4000 IU vitamin D daily
Trial: 20535051
Drug: Simulated acupuncture
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated acupuncture treatment
Trial: 8104730
Drug: Preoperative platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative platelet-rich plasma (PRP) 10 ml.kg-1
Trial: 8472058
Drug: Absolute decrease
RxNorm normalized name: Honey Absolute
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Absolute decrease in PEF of > or = 70 l.min‐1
Trial: 10836664
Drug: Benzalkonium chloride
RxNorm normalized name: Benzalkonium Chloride
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzalkonium chloride vaginal capsule
Trial: 29048187
Drug: Liquid nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liquid nicotine concentration of 36 mg/ml
Trial: 29048187
Drug: Liquid nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liquid nicotine concentration of 0, 8, 18, or 36 mg/ml
Trial: 16432825
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (flush ligation of sites of reflux, stripping of the long saphenous vein and multiple phlebectomies)
Trial: 25935783
Drug: TrimoSan gel
RxNorm normalized name: Triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TrimoSan gel (applied vaginally twice weekly)
Trial: 25935783
Drug: No gel
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No gel (standard pessary care)
Trial: 10673309
Drug: Interferon-alpha 2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 2b plus 200 mg ketoprofen three times a week
Trial: 19411529
Drug: Survey respondents
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Survey respondents comparing oral health to heart disease
Trial: 16769582
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific VOD prophylaxis or therapy (Control)
Trial: 2795401
Drug: Parent present
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent present during injection
Trial: 11986448
Drug: Cromolyn sodium
RxNorm normalized name: Cromolyn Sodium
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromolyn sodium nebulizer solution, 20 mg 4 times daily (n = 167)
Trial: 1835292
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (0.036 mg)
Trial: 3880993
Drug: Diltiazem 360
RxNorm normalized name: dilTIAZem 360 mg/24 hours oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 360 mg/day
Trial: 29562937
Drug: Intermittent renal
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent renal replacement therapy (IRRT)
Trial: 29562937
Drug: Continuous renal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous renal replacement therapy (CRRT)
Trial: 17060064
Drug: Diuretic (chlorthalidone)
RxNorm normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic (chlorthalidone)
Trial: 8123120
Drug: Chloroquine 300
RxNorm normalized name: chloroquine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 300 mg weekly and proguanil 100 mg daily
Trial: 9196769
Drug: Chloroquine 300
RxNorm normalized name: chloroquine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine 300 mg weekly and proguanil 200 mg daily
Trial: 9257749
Drug: Ciprofloxacin 400
RxNorm normalized name: ciprofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 400 mg intravenously twice a day for 4 days (Group B)
Trial: 29325799
Drug: Coexistence of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coexistence of HCY ≥ 14.65 μmol/l and hs-CRP ≥ 1.90 mg/l
Trial: 28092139
Drug: Occupational Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational Therapy (OT)
Trial: 3708119
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg furosemide tablet (Product 4)
Trial: 2678652
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g paracetamol
Trial: 28980198
Drug: Osmotic-release oral
RxNorm normalized name: nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Osmotic-release oral system methylphenidate (OROS-MPH)
Trial: 9505993
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of valspodar (200 mg as a 2-hour infusion)
Trial: 21797916
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel 10 g/day plus placebo pills
Trial: 10718681
Drug: Gabapentin (GBP)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (GBP) 1800 mg/day for 3 months
Trial: 8808415
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy intervention program (2.5-hr, 10-week activity-based program)
Trial: 29664801
Drug: Rectal Cancer
RxNorm normalized name: Cancer/testis antigen 1
DrugBank: Cancer/testis antigen 1 (DB19291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal Cancer Female Sexuality score (development and validation)
Trial: 25107840
Drug: Cytokine-induced killer
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytokine-induced killer (CIK) cell treatment
Trial: 15201546
Drug: Lisinopril 10-20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10-20 mg
Trial: 1563057
Drug: Epidural infusions
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusions of fentanyl combined with bupivacaine 0.1%
Trial: 8217999
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 50 mg/day (n = 10)
Trial: 29659405
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% hydroquinone (HQ) cream
Trial: 26051348
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) containing 843 mg (‐)‐epigallocatechin‐3‐gallate (EGCG)
Trial: 3708122
Drug: Single-unit tablets
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-unit tablets (control)
Trial: 17355735
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Dronabinol 10-20 mg, Ondansetron 8-16 mg)
Trial: 7557868
Drug: Ciprofloxacin 750
RxNorm normalized name: ciprofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 750 mg per os once a week for 6 months
Trial: 30354935
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) plus chemotherapy
Trial: 20185616
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy group
Trial: 27096538
Drug: Separated therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separated therapy (IPL followed by Nd:YAG treatment 3 days later)
Trial: 26350171
Drug: Drug holiday
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug holiday of 2 to 3 years after 3 to 5 years of BP treatment
Trial: 9278803
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (same drugs except for ketamine)
Trial: 21243762
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg, 3 times a week
Trial: 22374612
Drug: Injection group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection group (DXM 2.5 mg injected by tympanic membrane puncture at intervals of 2 days for a total of 4 occasions, total 10.0 mg)
Trial: 7525790
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with hyperthermia (group B)
Trial: 25230154
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg baclofen
Trial: 22054050
Drug: Lithium (0.6-1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (0.6-1.2 mEq/L)
Trial: 22054050
Drug: Quetiapine (300-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (300-800 mg/d)
Trial: 1812432
Drug: Cuban vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cuban vaccine against group B Neisseria meningitidis
Trial: 9793614
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of tramadol (2 ml solution for injection, 100 mg)
Trial: 9217894
Drug: Insulin with
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin with saline
Trial: 9217894
Drug: Insulin with
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin with indomethacin (0.65 microgram/kg/min)
Trial: 12482109
Drug: Pulsed estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed estrogen therapy (Aerodiol) at a dose of 300 microg/day
Trial: 2752040
Drug: TXB2 infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TXB2 infusion at 1.0 ng.kg‐1.min‐1
Trial: 29605029
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NAC) with fluorouracil, epirubicin, and cyclophosphamide
Trial: 9475275
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion (2.5 ng/kg/min)
Trial: 11561228
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg valsartan
Trial: 30973188
Drug: Dexamethasone 2
RxNorm normalized name: dexamethasone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 2 mg
Trial: 27993169
Drug: Individualized exercise
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized exercise prescription (ventilatory thresholds)
Trial: 19194342
Drug: St. John's
RxNorm normalized name: St. john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St. John's wort extract (900 mg TID)
Trial: 12012144
Drug: Test product
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test product (60 mg) after high-fat American breakfast
Trial: 8452109
Drug: Carboplatin 400
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin 400 mg/m2 by intravenous infusion for 30 minutes every 4 weeks
Trial: 19558539
Drug: Topiramate 100
RxNorm normalized name: topiramate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 100 mg/day
Trial: 15784033
Drug: IFN monotherapy
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN monotherapy for 24 weeks (group A: long-term IFN therapy)
Trial: 15784033
Drug: IFN monotherapy
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN monotherapy for 6 weeks (group B: short-term IFN therapy)
Trial: 12422252
Drug: Lidocaine without
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine without preservative (active drug)
Trial: 17848841
Drug: Somatropin Solution
RxNorm normalized name: Somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Somatropin Solution (Sandoz)
Trial: 8154412
Drug: Myocardial infarction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocardial infarction (MI) with no treatment
Trial: 16431305
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg once daily
Trial: 20054669
Drug: Response-oriented individualized
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Response-oriented individualized induction therapy with idarubicin (IDR) 12 mg/m2 for 3 days and cytarabine (Ara-C) 100 mg/m2 for 7 days, with additional IDR and Ara-C if bone marrow on day 8 did not become hypocellular with less than 15% blasts.
Trial: 31266412
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual education, cognitive rehabilitation training, and conventional treatment)
Trial: 25407349
Drug: Clinical medication
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical medication reviews (CMRs) facilitated by an expert team (GP and pharmacist)
Trial: 24584926
Drug: Subcutaneous abatacept
RxNorm normalized name: Abatacept
DrugBank: Abatacept (DB01281)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous abatacept (ABA) 125 mg/week
Trial: 9424900
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy
Trial: 1282588
Drug: Ro 42-5892
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 42-5892 (0.1 mg/kg) fast infusion
Trial: 25000151
Drug: Labisia pumila
RxNorm normalized name: Ulmus pumila pollen
DrugBank: Ulmus pumila pollen (DB10362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labisia pumila var alata water extract (400 mg)
Trial: 16429657
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg per day for 4 weeks before operation
Trial: 28252528
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg daily
Trial: 15305887
Drug: gliclazide MR
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gliclazide MR 30-120 mg daily
Trial: 15744631
Drug: Hypericum extract
RxNorm normalized name: Hypericum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum extract (612 mg)
Trial: 16023771
Drug: DTaP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTaP vaccine injected in the buttock
Trial: 9383806
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard-dose chemotherapy without GM-CSF)
Trial: 16110227
Drug: In-patient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-patient treatment (IP)
Trial: 11793035
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (oral tacrolimus 0.2 mg/kg daily + oral prednisone)
Trial: 30380948
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogens (CEE) plus 100 mg micronized progesterone (MP)
Trial: 30380948
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg CEE plus 100 mg MP
Trial: 3203706
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg furosemide
Trial: 16205336
Drug: Medical care
RxNorm normalized name: benzethonium Medicated Liquid Soap [Bedside-Care]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical care with and without physical therapy
Trial: 7437261
Drug: Antipyrine in
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine in patients treated with antiepileptic drugs
Trial: 9744695
Drug: Omeprazole infusion
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole infusion
Trial: 29324595
Drug: Antimuscarinic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimuscarinic therapy (4-8 mg daily)
Trial: 20688622
Drug: L-thyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-thyroxine (L-T4)
Trial: 20688622
Drug: L-thyroxine (L-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-thyroxine (L-T4) + L-triiodothyronine (L-T3)
Trial: 28417296
Drug: DPP4 inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP4 inhibitors
Trial: 15794387
Drug: Oral pirfenidone
RxNorm normalized name: Pirfenidone
DrugBank: Pirfenidone (DB04951)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral pirfenidone
Trial: 26856808
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (same pump parameters as during baseline evaluation)
Trial: 27044557
Drug: Intravenous thiamine
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous thiamine (200 mg)
Trial: 25393038
Drug: Subconjunctival Bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subconjunctival Bevacizumab (1.25 mg/0.05 mL)
Trial: 30408272
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (Control group)